Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
Journal: The New England journal of medicine
Published: August 31, 2026
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS).
Journal: American heart journal
Published: November 13, 2024
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Journal: Research and practice in thrombosis and haemostasis
Published: May 04, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Journal: Journal of the American Heart Association
Published: April 02, 2024
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.
Journal: Thrombosis and haemostasis
Published: November 23, 2023
Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-TIMI 51 trial.
Journal: Frontiers in cardiovascular medicine
Published: July 28, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Journal: Circulation
Published: May 08, 2023
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: March 22, 2023
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Journal: Journal of the American Heart Association
Published: October 07, 2022
Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: June 17, 2022
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Journal: Circulation
Published: April 07, 2022
Last Updated: 09/26/2026